Blueshift Reduces Bath & Body Works Stake by 105,980 Shares, Incurring ~$3.35 Million Loss
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 26 2025
0mins
Should l Buy BBWI?
Source: NASDAQ.COM
- Reduction Transaction: Blueshift Asset Management sold 105,980 shares of Bath & Body Works in Q3 2025, with an estimated transaction value of approximately $3.14 million, indicating a cautious outlook on the stock's future performance.
- Position Change: Following the sale, Blueshift holds 42,412 shares valued at about $1.09 million, reflecting a significant decline in confidence regarding its investment in Bath & Body Works.
- Market Reaction: After reaching a 52-week high of $41.87, the stock fell below $26 by the end of Q3 2025, highlighting increasing market concerns, particularly after a 1% year-over-year decline in net sales for Q3.
- Strategic Adjustment: The reduction has lowered Bath & Body Works' weight in Blueshift's portfolio to 0.34%, demonstrating a reassessment of the retail sector within the firm's diversified investment strategy.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy BBWI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on BBWI
Wall Street analysts forecast BBWI stock price to fall
14 Analyst Rating
4 Buy
10 Hold
0 Sell
Moderate Buy
Current: 22.860
Low
15.00
Averages
20.14
High
26.00
Current: 22.860
Low
15.00
Averages
20.14
High
26.00
About BBWI
Bath & Body Works, Inc. is a global omnichannel retailer focused on personal care and home fragrance. The Company offers a range of fragrances for the body and home, including selling collections for 3-wick candles, home fragrance diffusers, fine fragrance mists, liquid hand soaps, body lotions and body creams. It delivers customers their fragrances in multiple forms and categories. The Company sells merchandise through its retail stores in the United States and Canada, and through its Websites and other channels, under the Bath & Body Works, White Barn and other brand names. The Company’s international business is conducted through franchise, license and wholesale partners. It provides in-store experiences at more than 1,890 Company-operated Bath & Body Works locations in the United States and Canada, more than 525 international franchised locations and an online storefront at bathandbodyworks.com. Additionally, it offers a buy online pick-up in-store (BOPIS) option.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Class Action Lawsuit Filed Against Bath & Body Works, Inc.
- Lawsuit Background: Bath & Body Works, Inc. faces a class action lawsuit for alleged violations of federal securities laws, targeting investors who purchased the company's securities between June 4, 2024, and November 19, 2025, aiming to recover damages.
- False Statements Allegation: The complaint alleges that company executives made materially false and misleading statements during the class period, failing to disclose adverse facts about the company's business and financial outlook, misleading investors.
- Financial Guidance Missteps: The lawsuit highlights that the company's strategy of 'adjacencies, collaborations, and promotions' did not effectively grow the customer base and relied on brand collaborations to mask weak financial results, likely leading to unmet financial guidance.
- Investor Rights Protection: Investors in Bath & Body have until March 13, 2026, to apply as lead plaintiffs, with the law firm representing them on a contingency fee basis, ensuring that investor rights are restored in the process.
See More
Investigation into Bath & Body Works Securities Litigation
- Legal Investigation: Faruq & Faruq LLP is investigating potential claims against Bath & Body Works due to possible false statements made during securities transactions between June 4, 2024, and November 19, 2025, which may have harmed investors' rights.
- Declining Financial Performance: In Q3 2025, Bath & Body Works reported a 1% year-over-year revenue decline, missing its growth guidance of 1-3%, with net income plummeting 26% to $77 million, indicating a failure in the company's strategy.
- Acknowledgment of Strategic Failures: The company admitted during an investor presentation that its focus on “adjacencies, collaborations, and promotions” failed to effectively grow its customer base, leading to reduced investment in core categories and reliance on brand collaborations to mask weak financial results.
- Significant Stock Price Drop: Following the disappointing earnings report, Bath & Body Works' stock price fell by $5.22, or 24.8%, closing at $15.82 per share, reflecting market pessimism regarding the company's future prospects.
See More
Class Action Notice for Bath & Body Works Investors
- Class Action Timeline: Investors who purchased Bath & Body Works (NYSE: BBWI) securities between June 4, 2024, and November 19, 2025, should note that the deadline to apply as lead plaintiff is March 16, 2026, and failing to act may result in loss of compensation rights.
- Lawsuit Allegations: The lawsuit claims that the company made materially false statements during the class period, failing to disclose that its strategy of 'adjacencies, collaborations, and promotions' was not effectively growing its customer base, leading to investor losses when the truth emerged.
- Law Firm Credentials: The Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, being ranked first by ISS Securities Class Action Services in 2017, showcasing its expertise and success in this field.
- How to Participate: Investors can join the class action by visiting the Rosen Law Firm's website or calling toll-free at 866-767-3653 to ensure their rights are protected, emphasizing the importance of selecting qualified legal counsel over inexperienced intermediaries.
See More
Class Action Reminder for Bath & Body Works and BellRing Brands
- Bath & Body Works Lawsuit: Bath & Body Works faces a class action for failing to disclose that its strategy of 'adjacencies, collaborations, and promotions' did not effectively grow its customer base, resulting in a 1% year-over-year revenue decline in Q3 2025, missing the 1-3% growth guidance, and a 26% drop in net income to $77 million, highlighting the company's financial fragility.
- Guidance Downgrade: The company slashed its full-year net sales guidance below expectations and cut earnings per share from $3.28 to at least $2.83, indicating uncertainty in future profitability, which could undermine investor confidence.
- BellRing Brands Lawsuit: BellRing Brands is facing a class action for not disclosing that strong sales results were not due to increased consumer demand but rather excess inventory accumulated by customers due to previous product shortages, leading to a bleak 2025 sales outlook with net sales projected between $2.28 billion and $2.32 billion, reflecting weakening market demand.
- Significant Stock Declines: Following the disappointing financial reports, Bath & Body Works' stock plummeted 24.8% to close at $15.82 per share, while BellRing's stock dropped nearly 33% to $36.18 per share on August 5, 2025, indicating a pessimistic outlook for both companies' future performance.
See More
Bath & Body Works Shareholder Notice Issued
- Shareholder Notice Issued: The Gross Law Firm has issued a notice to shareholders of Bath & Body Works (NYSE:BBWI), encouraging those who purchased shares between June 4, 2024, and November 9, 2025, to contact the firm regarding potential lead plaintiff status, indicating the company is facing legal challenges.
- Allegations Overview: The lawsuit alleges that during the class period, Bath & Body Works made materially false statements and failed to disclose that its strategy of 'adjacencies, collaborations, and promotions' was not effectively growing its customer base, resulting in net sales growth falling short of expectations and impacting financial performance.
- Financial Guidance Missteps: The lawsuit highlights that the company is unlikely to meet its previously issued financial guidance, suggesting that management's positive statements lacked a reasonable basis, which could lead to diminished investor confidence and negatively affect stock performance.
- Registration Deadline: Shareholders must register for the class action by March 13, 2026, and upon registration, they will receive updates on the case's progress, demonstrating the potential impact of legal proceedings on investors.
See More
Securities Fraud Class Action Filed Against Bath & Body Works, Inc.
- Lawsuit Overview: Kessler Topaz Meltzer & Check, LLP has filed a securities fraud class action against Bath & Body Works, Inc. (NYSE: BBWI) on behalf of investors who purchased securities between June 4, 2024, and November 19, 2025, seeking recovery for losses due to alleged material misstatements and omissions.
- Allegation Details: The lawsuit alleges that Bath & Body Works failed to disclose that its strategy of pursuing 'adjacencies, collaborations, and promotions' was not effectively growing its customer base, leading to an inability to meet previously issued financial guidance, thereby misleading investors about the company's prospects.
- Investor Rights: Affected investors may seek to be appointed as lead plaintiffs in the class action by March 16, 2026, ensuring their rights to any potential recovery as representatives of all investors in the litigation.
- Law Firm Background: Kessler Topaz Meltzer & Check, LLP is a leading plaintiff-side law firm focused on securities fraud class actions, representing both individual and institutional investors, and has a strong track record of securing significant recoveries for clients.
See More
Class Action Lawsuit Filed Against Bath & Body Works, Inc.
- Lawsuit Background: Bath & Body Works, Inc. faces a class action lawsuit for alleged violations of federal securities laws, targeting investors who purchased the company's securities between June 4, 2024, and November 19, 2025, aiming to recover damages.
- False Statements Allegation: The complaint alleges that company executives made materially false and misleading statements during the class period, failing to disclose adverse facts about the company's business and financial outlook, misleading investors.
- Financial Guidance Missteps: The lawsuit highlights that the company's strategy of 'adjacencies, collaborations, and promotions' did not effectively grow the customer base and relied on brand collaborations to mask weak financial results, likely leading to unmet financial guidance.
- Investor Rights Protection: Investors in Bath & Body have until March 13, 2026, to apply as lead plaintiffs, with the law firm representing them on a contingency fee basis, ensuring that investor rights are restored in the process.
See More
Investigation into Bath & Body Works Securities Litigation
- Legal Investigation: Faruq & Faruq LLP is investigating potential claims against Bath & Body Works due to possible false statements made during securities transactions between June 4, 2024, and November 19, 2025, which may have harmed investors' rights.
- Declining Financial Performance: In Q3 2025, Bath & Body Works reported a 1% year-over-year revenue decline, missing its growth guidance of 1-3%, with net income plummeting 26% to $77 million, indicating a failure in the company's strategy.
- Acknowledgment of Strategic Failures: The company admitted during an investor presentation that its focus on “adjacencies, collaborations, and promotions” failed to effectively grow its customer base, leading to reduced investment in core categories and reliance on brand collaborations to mask weak financial results.
- Significant Stock Price Drop: Following the disappointing earnings report, Bath & Body Works' stock price fell by $5.22, or 24.8%, closing at $15.82 per share, reflecting market pessimism regarding the company's future prospects.
See More
Class Action Notice for Bath & Body Works Investors
- Class Action Timeline: Investors who purchased Bath & Body Works (NYSE: BBWI) securities between June 4, 2024, and November 19, 2025, should note that the deadline to apply as lead plaintiff is March 16, 2026, and failing to act may result in loss of compensation rights.
- Lawsuit Allegations: The lawsuit claims that the company made materially false statements during the class period, failing to disclose that its strategy of 'adjacencies, collaborations, and promotions' was not effectively growing its customer base, leading to investor losses when the truth emerged.
- Law Firm Credentials: The Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, being ranked first by ISS Securities Class Action Services in 2017, showcasing its expertise and success in this field.
- How to Participate: Investors can join the class action by visiting the Rosen Law Firm's website or calling toll-free at 866-767-3653 to ensure their rights are protected, emphasizing the importance of selecting qualified legal counsel over inexperienced intermediaries.
See More
Class Action Reminder for Bath & Body Works and BellRing Brands
- Bath & Body Works Lawsuit: Bath & Body Works faces a class action for failing to disclose that its strategy of 'adjacencies, collaborations, and promotions' did not effectively grow its customer base, resulting in a 1% year-over-year revenue decline in Q3 2025, missing the 1-3% growth guidance, and a 26% drop in net income to $77 million, highlighting the company's financial fragility.
- Guidance Downgrade: The company slashed its full-year net sales guidance below expectations and cut earnings per share from $3.28 to at least $2.83, indicating uncertainty in future profitability, which could undermine investor confidence.
- BellRing Brands Lawsuit: BellRing Brands is facing a class action for not disclosing that strong sales results were not due to increased consumer demand but rather excess inventory accumulated by customers due to previous product shortages, leading to a bleak 2025 sales outlook with net sales projected between $2.28 billion and $2.32 billion, reflecting weakening market demand.
- Significant Stock Declines: Following the disappointing financial reports, Bath & Body Works' stock plummeted 24.8% to close at $15.82 per share, while BellRing's stock dropped nearly 33% to $36.18 per share on August 5, 2025, indicating a pessimistic outlook for both companies' future performance.
See More
Bath & Body Works Shareholder Notice Issued
- Shareholder Notice Issued: The Gross Law Firm has issued a notice to shareholders of Bath & Body Works (NYSE:BBWI), encouraging those who purchased shares between June 4, 2024, and November 9, 2025, to contact the firm regarding potential lead plaintiff status, indicating the company is facing legal challenges.
- Allegations Overview: The lawsuit alleges that during the class period, Bath & Body Works made materially false statements and failed to disclose that its strategy of 'adjacencies, collaborations, and promotions' was not effectively growing its customer base, resulting in net sales growth falling short of expectations and impacting financial performance.
- Financial Guidance Missteps: The lawsuit highlights that the company is unlikely to meet its previously issued financial guidance, suggesting that management's positive statements lacked a reasonable basis, which could lead to diminished investor confidence and negatively affect stock performance.
- Registration Deadline: Shareholders must register for the class action by March 13, 2026, and upon registration, they will receive updates on the case's progress, demonstrating the potential impact of legal proceedings on investors.
See More
Securities Fraud Class Action Filed Against Bath & Body Works, Inc.
- Lawsuit Overview: Kessler Topaz Meltzer & Check, LLP has filed a securities fraud class action against Bath & Body Works, Inc. (NYSE: BBWI) on behalf of investors who purchased securities between June 4, 2024, and November 19, 2025, seeking recovery for losses due to alleged material misstatements and omissions.
- Allegation Details: The lawsuit alleges that Bath & Body Works failed to disclose that its strategy of pursuing 'adjacencies, collaborations, and promotions' was not effectively growing its customer base, leading to an inability to meet previously issued financial guidance, thereby misleading investors about the company's prospects.
- Investor Rights: Affected investors may seek to be appointed as lead plaintiffs in the class action by March 16, 2026, ensuring their rights to any potential recovery as representatives of all investors in the litigation.
- Law Firm Background: Kessler Topaz Meltzer & Check, LLP is a leading plaintiff-side law firm focused on securities fraud class actions, representing both individual and institutional investors, and has a strong track record of securing significant recoveries for clients.
See More
